Our Pipeline
TB Alliance manages the largest pipeline of new TB drugs in history.
The Senior Director, Clinical Development will be a key member of the TB Alliance Research and Development team and provide expertise necessary to develop strategy for clinical development programs and organize and manage clinical trials of promising anti-tuberculosis drugs. The Senior Director, Clinical Development reports to the Chief Medical Officer.
As part of our overall compensation package, we offer comprehensive health benefits, generous retirement contributions, and work/life flexibility designed to support you and your family.
Starting salary is expected to be in the range of US$280,000 - $350,000 exact salary will be commensurate with skills and experience and adjusted to reflect local currency for candidates outside the US.
Along with a competitive salary, TB Alliance offers superior employee benefits centered on medical insurance with very low co-payments, high levels of coverage, resulting in overall coverage valued at the 95th percentile. The package also includes vision, and dental insurance for employees, spouses, domestic partners, and dependent children, life insurance/accidental death. 100% of employee benefit costs are paid by the organization, with coverage effective day one of employment.
TB Alliance also offers a retirement savings program in the form of a 401k plan with generous employer contributions and employee matching.
Additionally, TB Alliance provides generous paid time-off, paid parental leave, paid family leave, flexible-hybrid work schedules, tuition reimbursement, student loan repayment assistance, as well as professional development opportunities for all staff.
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster, affordable tuberculosis drugs that are available to those who need them.Through innovative science and with partners around the globe, we lead a global effort to ensure development of and equitable access to faster, better tuberculosis cures that will advance global health and prosperity.
With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients. For more information, please access the website: www.tballiance.org.
TB Alliance manages the largest pipeline of new TB drugs in history.